Thomas Huber
27Patents
7h-index
61Co-inventors
72Inventor score
Filing activity: Sep 4, 1975 → Dec 20, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9777061B2 | Treatment of cancer using a CD33 chimeric antigen receptor | Chemistry; Metallurgy | 74 | Active |
| US9605070B2 | Antibody molecules to TIM-3 and uses thereof | Emerging Cross-Sectional Technologies | 50 | Active |
| US4112069A | Treatment of ruminants | Human Necessities | 14 | Expired |
| US4172127A | Treatment of ruminants | Emerging Cross-Sectional Technologies | 12 | Expired |
| US10472419B2 | Antibody molecules to TIM-3 and uses thereof | Emerging Cross-Sectional Technologies | 11 | Active |
| US9884913B2 | Antibody molecules to TIM-3 and uses thereof | Emerging Cross-Sectional Technologies | 11 | Active |
| US10981990B2 | Antibody molecules to TIM-3 and uses thereof | Emerging Cross-Sectional Technologies | 10 | Active |
| US11155620B2 | Method of detecting TIM-3 using antibody molecules to TIM-3 | Emerging Cross-Sectional Technologies | 5 | Active |
| US9498543B2 | Antibody drug conjugates | Chemistry; Metallurgy | 3 | Active |
| US9938342B2 | Nucleic acid encoding anti-IL-17A antibodies | Chemistry; Metallurgy | 3 | Active |
| US9789203B2 | cKIT antibody drug conjugates | Chemistry; Metallurgy | 3 | Active |
| US10117953B2 | Antibody drug conjugates | Chemistry; Metallurgy | 2 | Active |
| US10786578B2 | CKIT antibody drug conjugates | Chemistry; Metallurgy | 2 | Active |
| US9193788B2 | Anti-IL-17A antibodies and their uses | Chemistry; Metallurgy | 2 | Active |
| US10851166B2 | Treatment of cancer using a CD33 chimeric antigen receptor | Chemistry; Metallurgy | 1 | Active |
| US10005836B2 | Antibody drug conjugates | Physics | 1 | Active |
| US9650439B2 | Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory | Chemistry; Metallurgy | 1 | Active |
| US12325870B2 | Solubilized apyrases, methods and use | Chemistry; Metallurgy | 0 | Active |
| US12077580B2 | Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory disorders | Chemistry; Metallurgy | 0 | Active |
| US10167329B2 | Stabilized insulin-like growth factor polypeptides | Chemistry; Metallurgy | 0 | Active |
| USD1055702S1 | Pharmaceutical product container | General | 0 | Active |
| US10683349B2 | Anti-IL-17A antibodies and their use in treating autoimmune and inflammatory disorders | Chemistry; Metallurgy | 0 | Active |
| US10626172B2 | Antibody drug conjugates | Physics | 0 | Active |
| US8999320B2 | Nanoscale bound bilayers, methods of use and production | Human Necessities | 0 | Active |
| US12338287B2 | Treatment of cancer using a CD33 chimeric antigen receptor | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.